Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if LQDA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
59 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 1 days ago
Red flags: 0
336 filers reported a long position in LQDA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $860.2M | 10.8M | +96.5% |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $666.9M | 8.4M | -3.4% |
| Caligan Partners LP | $647.3M | 8.1M | Unchanged |
| FINDELL CAPITAL MANAGEMENT LLC | $279.2M | 3.5M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $250.3M | 3.1M | +7.3% |
| STATE STREET CORP | $241.6M | 3M | +61.1% |
| Opaleye Management Inc. | $195.1M | 2.4M | -3.8% |
| GEODE CAPITAL MANAGEMENT, LLC | $169.2M | 2.1M | +10% |
| BANK OF AMERICA CORP /DE/ | $158.8M | 2M | -12.9% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $154.7M | 1.9M | +103.6% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.